Nano-based delivery of RNAi in cancer therapy
Abstract Background RNA interference (RNAi), a newly developed method in which RNA molecules inhibit gene expression, has recently received considerable research attention. In the development of RNAi-based therapies, nanoparticles, which have distinctive size effects along with facile modification s...
Main Authors: | Yong Xin, Min Huang, Wen Wen Guo, Qian Huang, Long zhen Zhang, Guan Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12943-017-0683-y |
Similar Items
-
Nanoparticles as Drug Delivery Systems in Cancer Medicine: Emphasis on RNAi-Containing Nanoliposomes
by: Pablo E. Vivas-Mejia, et al.
Published: (2013-11-01) -
RNAi-Based Approaches for Pancreatic Cancer Therapy
by: Min Ju Kim, et al.
Published: (2021-10-01) -
Lipid-Based Nanocarriers in Renal RNA Therapy
by: Chi-Ting Su, et al.
Published: (2022-01-01) -
Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
by: Fiona van den Berg, et al.
Published: (2020-08-01) -
7.346 RNAi: A Revolution in Biology and Therapeutics, Spring 2010
by: Gurtan, Allan, et al.
Published: (2023)